1. Agbalika F., Fercahl F., Garnier J-P, et al.
1992. False-positive antigens related to emergence of a 25-30 protein detected
in organ recipients.
2. Andrade V., Avelleira JC., Marques A., et
al, 1991. Leprosy as a cause of false-positive results in serological assays
for the detection of antibodies to HIV-1. Intl. J. Leprosy. 59:125.
3. Arnold Nl., Slade R.A., Jones M.M., et al,
1994. Donor follow up of influenza vaccine-related multiple viral enzume
inmunoassay reactivity. Vox Sanguinis. 67:191.
4. Ascher D., Roberts C. 1993. Determination
of the etiology of seroreversals in HIV testing by antibody fingerprinting
AIDS. 6:241.
5. Barbacid M., Bolgnesi D., Aaronson S. 1980.
Humans have antibodies capable of recognizing oncoviral glucoproteins:
Demostration that these antibodies are formed in response to cellular modification
of glucoproteins rather than as consequence of exposure to virus. Proc.
Nathl. Acad. Sci. 77:1617-1621.
6. Biggar R., Melbye M., Sarin P., et al., 1985.
ELISA HTLV retrovirus antibody reactivity associated with malaria and immune
complexes in healthy Africans. Lancet. ii:520-543.
7. Blanton M., Balakrishnan K., Dumaswala U.,
et al, 1987. HLA antibodys in blood donors with reactive sreening tests
for antibodys to the immunodeficiency virus. Transfusión. 27 (1):118.
8. Blomberg J., Vincie E., Jonsson C., et al.
1990. Identification of long susthetic peptides AIDS Res. Hum. Retro. 6:1363.
9. Burkhardt U., Metens T., Eggers H. 1987. Comparison
of ELA and DuPont HTIV-III ELISA. J. Med. Vir. 23:217.
10. Bylund D., Ziegner U., Hooper D. 1992. Review
of testing for human immunodeficiency virus. Clin. Lab. Med. 12:305-333.
11. Challakere K., Rapaport M. 1993. False-positive
human inmunodeficiency virus type I ELISA results in low-risk subjects
West. J. Med. 159(2):214-215.
12. Charmot G., Simon F. 1990. HIV infection
and malaria. Revue du practicien, 40:2141.
13. Cordes R., Ryan M. 1995. Pittalls in HIV
testing. Postgraduate Medicine. 98:177.
14. Dock N., Lamberson H., O'Brien T., et al.,
1988. Evaluation of atypical human immunodeficiency virus immunoblot reactivity
in blood donors. Transfusion 28:142.
15. Esteva M., Blasini A., Ogly D., et al, 1992.
False positive results for antibody to HIV in two men with systemic lupus
erythematosus. Ann. Rheum. Dis., 51:1071-1073.
16 Fassbinder W., Kuhni P., Neumaver H., et
al, 1986. Prevalence of antibodies against LAV/HTLV-III (MIV) in patients
with termical renal insufficiency treated with hemodialysis and following
renal transplantation. Deutsche Medizinische Wochenschrift 111:1087.
17. Fleming D., Cochi S., Steece R., et al,
1987. Acquired immunodeficiency syndrome in low-incidence areas. JAMA 258(6):785.
18. Gill MJ., Rachlis A., Anand C. 1991. Five
cases of erroncously diagnosed HIV infection. Can. Med. Asso. J. 145(12):1593.
19. Healey D., Bolton iW. 1993. Apparent HIV-I
glycoprotein reactivity on Western blot in uninfected blood donors. AIDS.
7:655-658.
20. Hisa J., 1993. False-Positive ELISA for
human immunodeficiency virus after influenza vaccination HD. 167:989.
21. Isaacman S. 1989. Positive HIV antibody
test results after treatment with hepatitis B immune globulin. JAMA, 262:209.
22. Jackson G., Rubens M., Knigge M., et al,
1988. Passive immunoneutralisation of human immunodeficiency virus in patients
with advanced AIDS. Lancet. Sept. 17:647.
23. Jindal R., Solomon M., Burrows L. 1993.
False positive tests for HIV in a woman with lupus and renal failune. NEJM.
328:1281-1282.
24. Jungkind D., DiRenzo S., Young S. 1986.
Effect of using heat inactivated serum with the Abbott human T-cell lymphotropic
virus type III (HIV) antibody test. J. Clin. Micro. 23:381.
25. Kashala O., Marlink R., Ilunga M. et al.
1994. Infection with human immunodeficiency virus type I (HIV-I) and human
T-cell lymphotropic viruses among leprosy patients and contacts: correlation
between HIV-1 cross-reactivity and antibodies to lipoarabionomanna J. Infect.
Dis. 169:296-304.
26. Lai-Godman M., McBride J., Howanitz P.,
et al, 1987. Presence of HTLV-III (HIV) antibodies in immuneserum globulin
preparations. Am. J. Clin. Path. 87:635.
27. Langedjk J., Vos W., Doornum G., et al.
1992. Identification of cross-reactive epitopes recognized by HIV-1 fase-positive
será. AIDS. 6:1546-1548.
28. Lee D., Eby W., Molinaro G. 1992. HIV false
positivity after hepatitis B vaccination. Lancet 339:1060.
29. Leo-Amador G., Ramírez-Rodríguez
J., Galván-Villegas E., et al, 1990. Antibodies against human immunodeficiency
virus in generalized lupus erythematosus. Salud Pública de México.
32:15.
30. Mackenzie W., Davis J., Peterson D., et
al. 1992. Multiple false-positive serologie tests for HIV, HTLV-1 and hepatitis
C following influenza vaccination. 1991. JAMA. 268:1015-1017.
31. Mathe G. 1992. Is the AIDS virus responsible
for the disease?. Biomed & Pharmacother. 46:1-2.
32. Mendenhall C., Roselle G., Grossman C.,
et al. 1986. False-positive tests for HTLV-III (HIV) antibodies in alcoholic
patients with hepatitis. NEJM. 314:921.
33. Moore J., Cone E., Alexander S. 1986. HTLV-III
(HIV) seropositivity in 1971-1972 parenteral drug abusers -a case of false-positives
or evidence of viral exposure?. NEJM. 314:1387-1388.
34. Mortimer I., Mortimer J., Parry J. 1985.
Which anti-HTLV-III/LAV (HIV) assays for screening and comfirmatory testing?.
Lancet. Oct 10. p. 837.
35. Ncale T., Dagger J., Fong R., et al. 1985.
False-positive anti-HTLV-III (HIV) serology. New Zealand Med. J. October
23.
36. Ng V. 1991. Serological diagnosis with recombinant
peptides/proteins. Clin. Chem. 37:1667-1668.
37. Ozanne G., Fauvel M. 1988. Perfomance and
reliability of five commercial enzyme.linked immunosorbent assay kits in
screening for anti-human immunodeficiency virus antibody in high-risk subjects.
J. Clin. Micro, 26:1496.
38. Papadopulos-Eleopulos E. 1988. Reappraisal
of AIDS -Is the oxidation induced by the risk factors the primary cause?.
Med. Hypo. 25:151.
39. Papadopulos-Eleopulos E., Turner V. and
Papadimitriou J. 1993. Is a positive Western blot proof of HIV infection?.
Bio/technology. June 11:696/707.
40. Pearlman ES., Ballas SK. 1994. False-positive
human immunodeficiency virus screening test related to rabies vaccination.
Arch. Pathol. Lab. Med. 118-805.
41. Peternan T., Lang G., Mikos N., et Hemodialysis/renal
failure. 1986. JAMA. 255:2324.
42. Piszkewiez D. 1987. HTLV-III (HIV) antibodies
after immune globulin. JAMA. 257:316.
43. Profitt MR., Yen-Lieberman B. 1993. Laboratory
diagnosis of human immunodeficiency virus infection. Inf. Dis. Clin. North.
Am. 7:203.
44. Ranki A., Kurti P., Reipponen S., et al.
1992. Antibodies to retroviral proteins in autoimmune connective tissue
disease. Arthritis and Rheumatism. 35:1483.
45. Ribero T., Bries C., Moreira E., et al.
1993. Serologie validation of HIV infection in a tropical area. JAIDS.
6:319.
46. Savers M., Beatty P., Hansen J. 1986. HLA
antibodies as a cause of false-positive reactions in screening enzyme immunoassays
for antibodies to human T-lymphotropic virus type III (HIV). Transfusion.
26(1):114.
47. Sayre KR., Dodd RY., Tegtmeier G., et al,
1996. False-positive human immunodeficiency virus type 1 Western blot tests
in non infected blood donodrs. Transfusion. 36:45.
48. Schleupner CJ. Detection of HIV-1 infection.
In: (Mandell GI., Douglas RG., Bennet JE., eds.). Principles and Practice
of Infectious Diseases, 3rd ed. New York: Churchill Livingstone. 1990:1092.
49. Schochetman G., George J. 1992. Serologic
tests for the detection of human immunodeficiency virus infection. In AIDS
Testing Methodology and Management Issues, Springer-Verlag. New York.
50. Simonsen L., Buffington J., Shapiro C.,
et al. 1995. Multiple false reactions in viral antibody screening assays
after influenza vaccination. Am. J. Epidem. 141:1089.
51. Smith D., Dewhurst S., Shepherd S., et al.
1987. False-positive enzyme-linked immunosorbent assay reactions for antibody
to human immunodeficiency virus in a population of midwestern patients
with congenital bleeding disorders. Transfusion. 127:112.
52. Snyder H., Fleissner E. 1980. Specifity
of human antibodies to oncovirus glucoproteins; Recognition of antigen
by natural antibodies directed against carbohydrate structures. Proc. Natl.
Acad. Sci. 77:1622-1626.
53. Steckelberg JM., Cockerill F. 1988. Serologie
testing for human immunodeficiency virus antibodies. Mayo Clin. Proc. 63:373.
54. Sungar C., Akpolat T., Ozkuyumen C., et
al. Alpha interferon therapy in hemodialysis patients. Nephron. 67:251.
55. Tribe D., Reed D., Lindell P., et al. 1988.
Antibodies reactive with human immunodeficiency virus gag-coated antigens
(gag reactive only) are a major cause of enzyme-linked immunosorbent assay
reactivity in a bood donor population. J. Clin. Micro. April:641.
56. Ujhelyi E., Fust G., Illei G., et al. 1989.
Different types of false positive anti-HIV reactions in patients on hemodialysis.
Immun. Let. 22:35-40.
57. Van Beers D., Duys M. Maes M., et al. Heat
inactivation of serum may interfere with tests for antibodies to LAV/HTLV-III
(HIV). J. Vir. Meth. 12:329.
58. Voevodin A. 1992. HIV screening in Russia.
Lancet. 339:1548.
59. Weber B., Moshtaghi-Borogeni M., Brunner
M., et al. 1995. Evaluation of the reliability of six current anti-HIV-1/HIV-2
enzyme immunoassays. J. Vir. Meth. 55:97.
60. Wood C., Williams A., McNamara J., et al.
1986. Antibody against the human immunodeficiency virus in commercial intravenous
gammaglobulin preparations. Ann. Int. Med. 105:536.
61. Yale S., Degroen P., Tooson J., et al. 1994.
Unusual aspects of acute Q fever-associated hepatitis. Mayo Clin. Proc.
69:769.
62. Yoshida T., Matsui T., Kobayashi M., et
al. 1987. Evaluation of passive particle agglutination test for antibody
to human immunodeficiency virus. J. Clin. Micro. Aug:1433.
63. Yu S., Fong C., Landry M., et al. 1989.
A false positive HIV antibody reaction due to transfusion-induced HLA-DR4
sensitization. NEJM. 320:1495.
64. National Institute of Justice. AIDS Bulletin.
Oct. 1988.
Artículo publicado en el número 47 de la revista «Medicina
Holística». Edita: Asociación
de Medicinas Complementarias.